EN-US Tue, 18 Jun 2013 23:34:00 -0400 231858 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LIHDfVLdxW4/afterhours-earnings-report-for-march-28-2013-pcti-tzym-auxo-iliu-cm231858 News Headlines Earnings The following companies are expected to report earnings after hours on 03/28/2013. Visit our Earnings Calendar for a full list of expected earnings releases. PC-Tel, Inc. ( PCTI ) is<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/LIHDfVLdxW4" height="1" width="1"/> Thu, 28 Mar 2013 22:00:05 Z 2013-03-28T18:26:10Z NASDAQ.com News AUXO ILIU PCTI TZYM http://www.nasdaq.com/article/afterhours-earnings-report-for-march-28-2013-pcti-tzym-auxo-iliu-cm231858 204881 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a-PjwTcKv58/encouraging-news-for-tranzyme-pharma-analyst-blog-cm204881 Investing Business Stocks Biopharmaceutical company, Tranzyme Pharma ( TZYM ), announced recently the completion of its chemistry-based drug discovery partnership with pharma giant Bristol-Myers Squibb Company (<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/a-PjwTcKv58" height="1" width="1"/> Tue, 08 Jan 2013 03:30:01 Z 2013-01-08T00:02:30Z Zacks Equity Research BMY NVO TZYM http://www.nasdaq.com/article/encouraging-news-for-tranzyme-pharma-analyst-blog-cm204881 203619 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s2m9VH8KUBE/mixed-trial-results-from-omeros-analyst-blog-cm203619 Investing Business Stocks Omeros Corporation ( OMER ) recently reported mixed results from its first pivotal phase III study that was being conducted with OMS103HP in patients undergoing arthroscopic partial<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/s2m9VH8KUBE" height="1" width="1"/> Thu, 03 Jan 2013 04:05:01 Z 2013-01-03T01:00:49Z Zacks Equity Research OMER TZYM http://www.nasdaq.com/article/mixed-trial-results-from-omeros-analyst-blog-cm203619